Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1013243/000095014405011526/g96816q1e10vq.htm
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) August 3, 2005
aaiPharma
Inc.
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 0-21185 | 04-2687849 | ||
| (State or Other Jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
| of Incorporation) | Identification No.) |
2320 Scientific Park Drive
Wilmington, North Carolina 28405
Wilmington, North Carolina 28405
(Address of Principal Executive Offices)
(Zip Code)
(Zip Code)
(910) 254-7000
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former name or former address, if changed from last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4c))
The following information was filed by Aaipharma Inc on Tuesday, August 9, 2005 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Aaipharma Inc's financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aaipharma Inc.
1013243 Quarterly Reports
- 10-Q Quarterly Report November 2005
-
10-Q Quarterly Report November 2005
- 10-Q Quarterly Report May 2005
- 10-Q Quarterly Report November 2004
- 10-Q Quarterly Report August 2004
